DE69103908D1 - Verbessertes behandlungsverfahren für krebs. - Google Patents

Verbessertes behandlungsverfahren für krebs.

Info

Publication number: DE69103908D1
Authority: DE; Germany
Prior art keywords: chemotherapeutic agent; cancer cells; cancer treatment; treatment procedure; treatment
Prior art date: 1990-12-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

DE69103908T

Other languages

English (en)

Other versions

DE69103908T2 (de

Inventor

Lorne Brandes

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

University of Manitoba

Original Assignee

University of Manitoba

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-17

Filing date

1991-12-16

Publication date

1994-10-13

1991-12-16 Application filed by University of Manitoba filed Critical University of Manitoba

1994-10-13 Publication of DE69103908D1 publication Critical patent/DE69103908D1/de

1995-01-05 Application granted granted Critical

1995-01-05 Publication of DE69103908T2 publication Critical patent/DE69103908T2/de

2011-12-17 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Molecular Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DE69103908T 1990-12-17 1991-12-16 Verbessertes behandlungsverfahren für krebs. Expired - Fee Related DE69103908T2 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US62786390A	1990-12-17	1990-12-17
US71197591A	1991-06-07	1991-06-07
PCT/CA1991/000449 WO1992011035A1 (en)	1990-12-17	1991-12-16	Improved treatment method for cancer

Publications (2)

Publication Number	Publication Date
DE69103908D1 true DE69103908D1 (de)	1994-10-13
DE69103908T2 DE69103908T2 (de)	1995-01-05

Family

ID=27090549

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE69103908T Expired - Fee Related DE69103908T2 (de)	1990-12-17	1991-12-16	Verbessertes behandlungsverfahren für krebs.

Country Status (9)

Country	Link
EP (1)	EP0563127B1 (de)
JP (1)	JP2706371B2 (de)
AT (1)	ATE110966T1 (de)
AU (1)	AU664978B2 (de)
CA (1)	CA2098593C (de)
DE (1)	DE69103908T2 (de)
DK (1)	DK0563127T3 (de)
ES (1)	ES2063574T3 (de)
WO (1)	WO1992011035A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9303210D0 (en) *	1993-02-17	1993-03-31	Univ Manitoba	Cancer treatment
AU749157B2 (en) *	1993-02-17	2002-06-20	University Of Manitoba	Cancer treatment
US5432168A (en) *	1993-12-27	1995-07-11	University Of Manitoba	Method of treatment of hormone-unresponsive metastatic prostate cancer
US5585492A (en) *	1994-10-11	1996-12-17	G. D. Searle & Co.	LTA4 Hydrolase inhibitors
US6506876B1 (en) *	1994-10-11	2003-01-14	G.D. Searle & Co.	LTA4 hydrolase inhibitor pharmaceutical compositions and methods of use
US5863912A (en) *	1994-12-07	1999-01-26	Manitoba Cancer Treatment And Research Foundation	Method of treatment of hormone-unresponsive metastiatic prostate cancer
US6939541B2 (en) *	2000-04-14	2005-09-06	University Of South Carolina	Cloning, overexpression and therapeutic use of bioactive histidine ammonia lyase
US6630454B2 (en) *	2001-09-10	2003-10-07	Ramot At Tel-Aviv University Ltd.	Method and pharmaceutical composition for the treatment of cancer
JP2005512996A (ja) *	2001-11-09	2005-05-12	ユニヴァーシティオブマニトーバ	乳癌の治療
US20060089317A1 (en) *	2002-09-04	2006-04-27	The University Of Manitoba	Treatment of metastatic breast cancer with anthracyclines, and taxanes
EP3368024B1 (de) *	2015-10-27	2023-09-20	Akos Biosciences, Inc.	Zusammensetzungen mit cannabidiol und zweiten therapeutischen mitteln zur behandlung von krebs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1229604A (en) *	1984-02-14	1987-11-24	Lorne J. Brandes	Aminoalkyl ethers of phenols as antiproliferative anticancer agents

1991
- 1991-12-16 ES ES92901177T patent/ES2063574T3/es not_active Expired - Lifetime
- 1991-12-16 DE DE69103908T patent/DE69103908T2/de not_active Expired - Fee Related
- 1991-12-16 AT AT92901177T patent/ATE110966T1/de not_active IP Right Cessation
- 1991-12-16 DK DK92901177.3T patent/DK0563127T3/da active
- 1991-12-16 WO PCT/CA1991/000449 patent/WO1992011035A1/en not_active Ceased
- 1991-12-16 AU AU90583/91A patent/AU664978B2/en not_active Ceased
- 1991-12-16 JP JP4502021A patent/JP2706371B2/ja not_active Expired - Fee Related
- 1991-12-16 EP EP92901177A patent/EP0563127B1/de not_active Expired - Lifetime
- 1991-12-16 CA CA002098593A patent/CA2098593C/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
AU9058391A (en)	1992-07-22
EP0563127A1 (de)	1993-10-06
CA2098593A1 (en)	1992-06-18
EP0563127B1 (de)	1994-09-07
JPH06505710A (ja)	1994-06-30
JP2706371B2 (ja)	1998-01-28
CA2098593C (en)	1999-08-10
DK0563127T3 (da)	1994-11-28
AU664978B2 (en)	1995-12-14
ATE110966T1 (de)	1994-09-15
WO1992011035A1 (en)	1992-07-09
ES2063574T3 (es)	1995-01-01
DE69103908T2 (de)	1995-01-05

Similar Documents

Publication	Publication Date	Title
CY1105788T1 (el)	2011-02-02	Χρηση του taci σαν παραγοντα καταπολεμησης ογκων
PT1033981E (pt)	2004-08-31	Formulacoes e metodos para reduzir a toxicidade de agentes antineoplasicos
DE69103908D1 (de)	1994-10-13	Verbessertes behandlungsverfahren für krebs.
MY101207A (en)	1991-08-17	Treatment of diseases caused by retroviruses
KR930003912A (ko)	1993-03-22	울혈성 심장 마비 치료법
EP0214501A3 (en)	1987-09-09	Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
ES2075468T3 (es)	1995-10-01	Vehiculos de suministro de farmacos suspendidos en un portador perfluorado no acuoso.
DE69836222D1 (de)	2006-11-30	Modifizierter tumor-nekrosefaktor
NL190397B (nl)	1993-09-16	Dialysesonde voor toepassing in een biologisch weefsel, zoals hersenweefsel.
LV10183A (lv)	1994-10-20	Perorala kompozicija zarnu iekaisuma slimibu arstesanai
WO1998022141A3 (en)	1999-01-07	Enhanced effects for hapten conjugated therapeutics
TR200101633T2 (tr)	2002-06-21	Farmasötik bileşim
SE8303003D0 (sv)	1983-05-27	Medel for att oka antitumorverkan hos antitumormedel
MX9102701A (es)	1992-06-01	Derivados de 2-acilamido de 3,4-dihidro-3-oxo-quinoxalina que tienen actividad farmaceutica.
JPS5735516A (en)	1982-02-26	Agent for increasing radiosensitivity or agent for increasing effect of substance having activity similar to radiation
TR199900951T2 (xx)	1999-07-21	G��s kanserinin engellenmesi i�in y�ntemler.
ES2128043T3 (es)	1999-05-01	Uso de bis(amidinobencimidazoles) en la preparacion de un medicamento para inhibir la integrasa retroviral.
Pirker et al.	1989	Enhancement of the activity of immunotoxins by analogues of verapamil
PT1102594E (pt)	2002-10-31	Utilizacao de cloreto de sodio para reduzir a toxicidade gastrointestinal de derivados de camptotecina
ES465215A1 (es)	1978-11-16	Procedimiento para la preparacion de compuestos poliomeri- cos.
IL101675A0 (en)	1992-12-30	Method and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors
KR927002224A (ko)	1992-09-03	항종양효과증강제 및 항종양제
BE1000723A4 (fr)	1989-03-21	Utilisation de gangliosides exogenes dans des maladies tumorales comme facteur de protection contre la toxicite de medicaments antitumoraux.
EP0494247A4 (de)	1994-03-30
DE3163920D1 (en)	1984-07-05	Pharmaceutical preparations comprising polyprenyl compounds, especially as anti-cancer agents, and pharmaceutical compositions for the prevention and treatment of cancer and skin diseases

Legal Events

Date	Code	Title	Description
1995-10-05	8364	No opposition during term of opposition
2009-10-22	8339	Ceased/non-payment of the annual fee